Martin Lackmann
VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: June 13, 2017
EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia.
Journal: Leukemia
Published: July 10, 2016
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth.
Journal: The Journal of experimental medicine
Published: July 02, 2015
PTP-PEST controls EphA3 activation and ephrin-induced cytoskeletal remodelling.
Journal: Journal of cell science
Published: May 25, 2015
The role of proteases in regulating Eph/ephrin signaling.
Journal: Cell adhesion & migration
Published: December 09, 2014
Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironment.
Journal: Cancer research
Published: August 16, 2014
A mathematical model for eph/ephrin-directed segregation of intermingled cells.
Journal: PloS one
Published: August 07, 2014
Therapeutic targeting of EPH receptors and their ligands.
Journal: Nature reviews. Drug discovery
Published: January 01, 2014
Antibodies binding the ADAM10 substrate recognition domain inhibit Eph function.
Journal: Journal of cell science
Published: October 31, 2012
Last Updated: 09/26/2026